Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Organoid-on-a-chip and body-on-a-chip systems for drug screening and disease modeling.

Drug discovery today·2016
Same author

A tunable hydrogel system for long-term release of cell-secreted cytokines and bioprinted in situ wound cell delivery.

Journal of biomedical materials research. Part B, Applied biomaterials·2016
Same author

Re: A Tumor Mitochondria Vaccine Protects against Experimental Renal Cell Carcinoma.

The Journal of urology·2016
Same author

Re: Endogenous Formaldehyde is a Hematopoietic Stem Cell Genotoxin and Metabolic Carcinogen.

The Journal of urology·2016
Same author

Re: Sphaeropsidin A Shows Promising Activity against Drug-Resistant Cancer Cells by Targeting Regulatory Volume Increase.

The Journal of urology·2016
Same author

Re: Sex Hormone-Dependent tRNA Halves Enhance Cell Proliferation in Breast and Prostate Cancers.

The Journal of urology·2016

Related Experiment Video

Updated: May 19, 2026

Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications
10:30

Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications

Published on: December 8, 2016

Amniotic fluid-derived stem cells as a cell source for bone tissue engineering.

Márcia T Rodrigues1, Sang Jin Lee, Manuela E Gomes

  • 1Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.

Tissue Engineering. Part A
|August 16, 2012
PubMed
Summary
This summary is machine-generated.

Bone marrow-derived stem cells (BMSCs) and amniotic fluid-derived stem cells (AFSCs) can both differentiate into bone cells. Cell origin and culture environment significantly impact osteogenic differentiation, revealing new possibilities for bone tissue regeneration.

More Related Videos

Integrated Bone Formation Through In Vivo Endochondral Ossification Using Mesenchymal Stem Cells
06:05

Integrated Bone Formation Through In Vivo Endochondral Ossification Using Mesenchymal Stem Cells

Published on: July 14, 2023

Use of Human Perivascular Stem Cells for Bone Regeneration
07:05

Use of Human Perivascular Stem Cells for Bone Regeneration

Published on: May 25, 2012

Related Experiment Videos

Last Updated: May 19, 2026

Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications
10:30

Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications

Published on: December 8, 2016

Integrated Bone Formation Through In Vivo Endochondral Ossification Using Mesenchymal Stem Cells
06:05

Integrated Bone Formation Through In Vivo Endochondral Ossification Using Mesenchymal Stem Cells

Published on: July 14, 2023

Use of Human Perivascular Stem Cells for Bone Regeneration
07:05

Use of Human Perivascular Stem Cells for Bone Regeneration

Published on: May 25, 2012

Area of Science:

  • Tissue Engineering
  • Regenerative Medicine
  • Stem Cell Biology

Background:

  • Bone marrow-derived stem cells (BMSCs) are the gold standard for orthopedic tissue engineering due to their osteogenic potential.
  • Novel stem cell sources like amniotic fluid-derived stem cells (AFSCs) offer unique features for bone regeneration.
  • Understanding stem cell differentiation is crucial for advancing tissue engineering applications.

Purpose of the Study:

  • To compare the osteogenic potential of BMSCs and AFSCs.
  • To investigate the influence of cell origin on osteogenic differentiation.
  • To evaluate the impact of distinct 2D and 3D culture environments on stem cell differentiation.

Main Methods:

  • Osteogenic differentiation of BMSCs and AFSCs in 2D (tissue culture plate) and 3D (starch and poly(ɛ-caprolactone) scaffolds).
  • Analysis of mineralized extracellular matrix production.
  • Assessment of bone-related marker expression and differentiation timing.

Main Results:

  • Both BMSCs and AFSCs successfully differentiated into osteogenic cells, producing mineralized extracellular matrix.
  • Distinct expression patterns of bone-related markers were observed between BMSCs and AFSCs.
  • Differences in differentiation timing were noted, highlighting the influence of cell origin and culture environment.

Conclusions:

  • Both cell origin and culture environment significantly impact osteogenic differentiation in BMSCs and AFSCs.
  • AFSCs present a promising alternative stem cell source for bone tissue engineering.
  • Further research into optimizing culture conditions for specific stem cell sources is warranted for enhanced bone regeneration.